VERV

Verve Therapeutics, Inc. is a biotechnology company pioneering gene editing medicines to treat cardiovascular disease. Their lead programs are focused on permanently turning off the PCSK9 gene in the liver to lower LDL cholesterol and reduce the risk of heart attacks. The… Who owns VERV? Institutional holders, 13F…

Verve Therapeutics, Inc. is a biotechnology company pioneering gene editing medicines to treat cardiovascular disease. Their lead programs are focused on permanently turning off the PCSK9 gene in the liver to lower LDL cholesterol and reduce the risk of heart attacks. The…

Canonical: https://longshort.io/ticker/VERV